Skip Navigation

Phase I BCMA CAR T Trial in Relapsed or Refractory Multiple Myeloma Using our Next Generation of Investigational CAR-T Product Generated by a Unique Manufacturing Platform NEX-T

Brief Summary

Type:
Multiple Myeloma

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04394650

Study #:
STUDY00145338

Start Date:
Oct 28, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04394650

View Complete Trial Details & Eligibility at ClinicalTrials.gov